Bayer, a struggling pharmaceutical giant, is undergoing a significant transformation to address financial challenges and bureaucratic hurdles, as reported by Fortune magazine.

CEO Bill Anderson aims to save $2.15 billion by eliminating middle managers and streamlining the company’s structure.

This move involves transitioning to a “boss-less” model, allowing nearly 100,000 employees to self-manage in dynamic shared ownership teams.

Anderson believes this approach will empower employees, enhance efficiency, and foster innovation. The decision follows widespread dissatisfaction among employees with the existing hierarchy and bureaucratic processes, which hindered productivity and stifled creativity.

Despite skepticism, Anderson sees this as a revolutionary step towards revitalising Bayer’s fortunes. The company’s massive debt and legal battles, particularly regarding its acquisition of Monsanto, underscore the urgency of the restructuring efforts.

While cutting middle management is not novel in the corporate world, Bayer’s scale and ambition make this undertaking noteworthy. Similar initiatives have been seen in other industries, with companies like Meta and Google restructuring to streamline operations and improve efficiency.

As Bayer embarks on this transformative journey, the success of its bold strategy remains to be seen, with implications not only for the company but also for the broader corporate landscape.